Precision Oncology Market Forecast (2024-2032)

The Precision Oncology Market study helps to evaluate a variety of essential variables, including product success, market share expansion, and investment in a developing market, to mention a few. The most recent report will give you an overview of the Precision Oncology Market as a whole, as well as aspects that may impact future growth, prospective opportunities, and present trends. The research examines the revenue market size, as well as market drivers, restraints, and opportunities. The report also illustrates the competitive landscape of the industry’s leading competitors, as well as the top companies’ percentage market share.
This study investigates market structure, segmentation, growth rates, and revenue share comparisons. This research provides a high-level overview of the market and its opportunities. This report goes thoroughly into the Precision Oncology Market. The market estimations and predictions in the research study are based on thorough secondary research, primary interviews, and expert opinions from within the organization. These market projections and estimations take into account a range of political, social, and economic aspects, as well as existing market conditions, when calculating market growth.

Market Segmentation
This study investigates revenue growth at the national level, as well as current industry changes in each sub-segment. This segmentation provides a thorough perspective of the market and enables you to monitor its evolution. This section looks at how the Precision Oncology Market is segmented by regions and nations, as well as a breakdown of revenue, market share, and future growth opportunities.

Key Segments:
By Product Type

• Diagnostics
• Therapeutics

By Cancer Type

• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Prostate Cancer
• Lung Cancer
• Others

By End Use

• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Healthcare Data Companies

An analysis of the COVID-19 impact
The impact of COVID-19 on the precision oncology market at the national level is examined in this research study. Market players will benefit from the COVID-19 impact analysis as they put their pandemic preparation plans into action. The target market’s supply and demand side effects are taken into account in this research. This study made use of private databases, a paid data source, primary and secondary research, and more.

Key Market Players:

• Thermo Fisher Scientific Inc.
• Invitae Corporation
• Qiagen N.V.
• Illumina Inc.
• Laboratory Corporation of America Holding
• Exact Sciences Corporation
• Rain Oncology Inc.
• Strata Oncology Inc.
• Xilis Inc.
• Variantyx Inc.
• Bioserve
• Relay Therapeutics
• Acrivon Therapeutics and other.

Table of Contents

1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges

4. Impact Analysis
4.1 Impact of the Ukraine- Russia War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. Precision Oncology Market Segmentation, By Product Type
8.1    Diagnostics
8.2    Therapeutics 

9. Precision Oncology Market Segmentation, By Cancer Type
9.1    Breast Cancer
9.2    Colorectal Cancer
9.3    Cervical Cancer
9.4    Prostate Cancer
9.5    Lung Cancer
9.6    Others

10. Precision Oncology Market Segmentation, By End Use
10.1 Hospitals & Diagnostic Laboratories
10.2 Pharmaceutical & Biotechnology Companies
10.3 Healthcare Data Companies 

11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Precision Oncology Market by Country
11.2.2North America Precision Oncology Market by Type
11.2.3 North America Precision Oncology Market by Cancer Type
11.2.4 North America Precision Oncology Market by End Use
11.2.5 USA
11.2.5.1 USA Precision Oncology Market by Type
11.2.5.2 USA Precision Oncology Market by Cancer Type
11.2.5.3 USA Precision Oncology Market by End Use
11.2.6 Canada
11.2.6.1 Canada Precision Oncology Market by Type
11.2.6.2 Canada Precision Oncology Market by Cancer Type
11.2.6.3 Canada Precision Oncology Market by End Use
11.2.7 Mexico
11.2.7.1 Mexico Precision Oncology Market by Type
11.2.7.2 Mexico Precision Oncology Market by Cancer Type
11.2.7.3 Mexico Precision Oncology Market by End Use
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Precision Oncology Market by Country
11.3.1.2 Eastern Europe Precision Oncology Market by Type
11.3.1.3 Eastern Europe Precision Oncology Market by Cancer Type
11.3.1.4 Eastern Europe Precision Oncology Market by End Use
11.3.1.5 Poland
11.3.1.5.1 Poland Precision Oncology Market by Type
11.3.1.5.2 Poland Precision Oncology Market by Cancer Type
11.3.1.5.3 Poland Precision Oncology Market by End Use
11.3.1.6 Romania
11.3.1.6.1 Romania Precision Oncology Market by Type
11.3.1.6.2 Romania Precision Oncology Market by Cancer Type
11.3.1.6.4 Romania Precision Oncology Market by End Use
11.3.1.7 Turkey
11.3.1.7.1 Turkey Precision Oncology Market by Type
11.3.1.7.2 Turkey Precision Oncology Market by Cancer Type
11.3.1.7.3 Turkey Precision Oncology Market by End Use
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Precision Oncology Market by Type
11.3.1.8.2 Rest of Eastern Europe Precision Oncology Market by Cancer Type
11.3.1.8.3 Rest of Eastern Europe Precision Oncology Market by End Use
11.3.2 Western Europe
11.3.2.1 Western Europe Precision Oncology Market by Type
11.3.2.2 Western Europe Precision Oncology Market by Cancer Type
11.3.2.3 Western Europe Precision Oncology Market by End Use
11.3.2.4 Germany
11.3.2.4.1 Germany Precision Oncology Market by Type
11.3.2.4.2 Germany Precision Oncology Market by Cancer Type
11.3.2.4.3 Germany Precision Oncology Market by End Use
11.3.2.5 France
11.3.2.5.1 France Precision Oncology Market by Type
11.3.2.5.2 France Precision Oncology Market by Cancer Type
11.3.2.5.3 France Precision Oncology Market by End Use
11.3.2.6 UK
11.3.2.6.1 UK Precision Oncology Market by Type
11.3.2.6.2 UK Precision Oncology Market by Cancer Type
11.3.2.6.3 UK Precision Oncology Market by End Use
11.3.2.7 Italy
11.3.2.7.1 Italy Precision Oncology Market by Type
11.3.2.7.2 Italy Precision Oncology Market by Cancer Type
11.3.2.7.3 Italy Precision Oncology Market by End Use
11.3.2.8 Spain
11.3.2.8.1 Spain Precision Oncology Market by Type
11.3.2.8.2 Spain Precision Oncology Market by Cancer Type
11.3.2.8.3 Spain Precision Oncology Market by End Use
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Precision Oncology Market by Type
11.3.2.9.2 Netherlands Precision Oncology Market by Cancer Type
11.3.2.9.3 Netherlands Precision Oncology Market by End Use
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Precision Oncology Market by Type
11.3.2.10.2 Switzerland Precision Oncology Market by Cancer Type
11.3.2.10.3 Switzerland Precision Oncology Market by End Use
11.3.2.11. Austria
11.3.2.11.1 Austria Precision Oncology Market by Type
11.3.2.11.2 Austria Precision Oncology Market by Cancer Type
11.3.2.11.3 Austria Precision Oncology Market by End Use
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Precision Oncology Market by Type
11.3.2.12.2 Rest of Western Europe Precision Oncology Market by Cancer Type
11.3.2.12.3 Rest of Western Europe Precision Oncology Market by End Use
11.4 Asia-Pacific
11.4.1 Asia-Pacific Precision Oncology Market by Country
11.4.2 Asia-Pacific Precision Oncology Market by Type
11.4.3 Asia-Pacific Precision Oncology Market by Cancer Type
11.4.4 Asia-Pacific Precision Oncology Market by End Use
11.4.5 China
11.4.5.1 China Precision Oncology Market by Type
11.4.5.2 China Precision Oncology Market by Cancer Type
11.4.5.3 China Precision Oncology Market by End Use
11.4.6 India
11.4.6.1 India Precision Oncology Market by Type
11.4.6.2 India Precision Oncology Market by Cancer Type
11.4.6.3 India Precision Oncology Market by End Use
11.4.7 Japan
11.4.7.1 Japan Precision Oncology Market by Type
11.4.7.2 Japan Precision Oncology Market by Cancer Type
11.4.7.3 Japan Precision Oncology Market by End Use
11.4.8 South Korea
11.4.8.1 South Korea Precision Oncology Market by Type
11.4.8.2 South Korea Precision Oncology Market by Cancer Type
11.4.8.3 South Korea Precision Oncology Market by End Use
11.4.9 Vietnam
11.4.9.1 Vietnam Precision Oncology Market by Type
11.4.9.2 Vietnam Precision Oncology Market by Cancer Type
11.4.9.3 Vietnam Precision Oncology Market by End Use
11.4.10 Singapore
11.4.10.1 Singapore Precision Oncology Market by Type
11.4.10.2 Singapore Precision Oncology Market by Cancer Type
11.4.10.3 Singapore Precision Oncology Market by End Use
11.4.11 Australia
11.4.11.1 Australia Precision Oncology Market by Type
11.4.11.2 Australia Precision Oncology Market by Cancer Type
11.4.11.3 Australia Precision Oncology Market by End Use
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Precision Oncology Market by Type
11.4.12.2 Rest of Asia-Pacific Precision Oncology Market by Cancer Type
11.4.12.3 Rest of Asia-Pacific Precision Oncology Market by End Use
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Precision Oncology Market by Country
11.5.1.2 Middle East Precision Oncology Market by Type
11.5.1.3 Middle East Precision Oncology Market by Cancer Type
11.5.1.4 Middle East Precision Oncology Market by End Use
11.5.1.5 UAE
11.5.1.5.1 UAE Precision Oncology Market by Type
11.5.1.5.2 UAE Precision Oncology Market by Cancer Type
11.5.1.5.3 UAE Precision Oncology Market by End Use
11.5.1.6 Egypt
11.5.1.6.1 Egypt Precision Oncology Market by Type
11.5.1.6.2 Egypt Precision Oncology Market by Cancer Type
11.5.1.6.3 Egypt Precision Oncology Market by End Use
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Precision Oncology Market by Type
11.5.1.7.2 Saudi Arabia Precision Oncology Market by Cancer Type
11.5.1.7.3 Saudi Arabia Precision Oncology Market by End Use
11.5.1.8 Qatar
11.5.1.8.1 Qatar Precision Oncology Market by Type
11.5.1.8.2 Qatar Precision Oncology Market by Cancer Type
11.5.1.8.3 Qatar Precision Oncology Market by End Use
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Precision Oncology Market by Type
11.5.1.9.2 Rest of Middle East Precision Oncology Market by Cancer Type
11.5.1.9.3 Rest of Middle East Precision Oncology Market by End Use
11.5.2 Africa
11.5.2.1 Africa Transfusion Diagnostics Market by Country
11.5.2.2 Africa Precision Oncology Market by Type
11.5.2.3 Africa Precision Oncology Market by Cancer Type
11.5.2.4 Africa Precision Oncology Market by End Use
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Precision Oncology Market by Type
11.5.2.5.2 Nigeria Precision Oncology Market by Cancer Type
11.5.2.5.3 Nigeria Precision Oncology Market by End Use
11.5.2.6 South Africa
11.5.2.6.1 South Africa Precision Oncology Market by Type
11.5.2.6.2 South Africa Precision Oncology Market by Cancer Type
11.5.2.6.3 South Africa Precision Oncology Market by End Use
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Precision Oncology Market by Type
11.5.2.7.2 Rest of Africa Precision Oncology Market by Cancer Type
11.5.2.7.3 Rest of Africa Precision Oncology Market by End Use
11.6 Latin America
11.6.1 Latin America Precision Oncology Market by Country
11.6.2 Latin America Precision Oncology Market by Type
11.6.3 Latin America Precision Oncology Market by Cancer Type
11.6.4 Latin America Precision Oncology Market by End Use
11.6.5 Brazil
11.6.5.1 Brazil Precision Oncology Market by Type
11.6.5.2 Brazil Precision Oncology Market by Cancer Type
11.6.5.3 Brazil Precision Oncology Market by End Use
11.6.6 Argentina
11.6.6.1 Argentina Precision Oncology Market by Type
11.6.6.2 Argentina Precision Oncology Market by Cancer Type
11.6.6.3 Argentina Precision Oncology Market by End Use
11.6.7 Colombia
11.6.7.1 Colombia Precision Oncology Market by Type
11.6.7.2 Colombia Precision Oncology Market by Cancer Type
11.6.7.3 Colombia Precision Oncology Market by End Use
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Precision Oncology Market by Type
11.6.8.2 Rest of Latin America Precision Oncology Market by Cancer Type
11.6.8.3 Rest of Latin America Precision Oncology Market by End Use

12. Company profile
12.1 Thermo Fisher Scientific Inc.
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Product/ Services Offered
12.1.4 SWOT Analysis
12.1.5 Publishers View
12.2 Invitae Corporation
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/ Services Offered
12.2.4 SWOT Analysis
12.2.5 Publishers View
12.3 Qiagen N.V.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/ Services Offered
12.3.4 SWOT Analysis
12.3.5 Publishers View
12.4 Illumina, Inc.
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/ Services Offered
12.4.4 SWOT Analysis
12.4.5 Publishers View
12.5 Laboratory Corporation of America Holding
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/ Services Offered
12.5.4 SWOT Analysis
12.5.5 Publishers View
12.6 Exact Sciences Corporation
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/ Services Offered
12.6.4 SWOT Analysis
12.6.5 Publishers View
12.7 Rain Oncology Inc.
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/ Services Offered
12.7.4 SWOT Analysis
12.7.5 Publishers View
12.8 Strata Oncology, Inc.
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Product/ Services Offered
12.8.4 SWOT Analysis
12.8.5 Publishers View
12.9 Xilis, Inc.
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/ Services Offered
12.9.4 SWOT Analysis
12.9.5 Publishers View
12.10 Variantyx, Inc.
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/ Services Offered
12.10.4 SWOT Analysis
12.10.5 Publishers View
12.11 Bioserve
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Product/ Services Offered
12.11.4 SWOT Analysis
12.11.5 Publishers View
12.12 Relay Therapeutics
12.12.1 Company Overview
12.12.2 Financials
12.12.3 Product/ Services Offered
12.12.4 SWOT Analysis
12.12.5 The SNS View
12.13 Acrivon Therapeutics
12.13.1 Company Overview
12.13.2 Financials
12.13.3 Product/ Services Offered
12.13.4 SWOT Analysis
12.13.5 Publishers View

13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions

14. Use Cases and Best Practices

15. Conclusion